Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease

K. Vonbank, G. Funk, R. Ziesche, V. Petkov, L. Stiebellehner, P. Schenk, P. Haber (Vienna, Austria)

Source: Annual Congress 2002 - Exercise and rehabilitation in patients with COPD
Session: Exercise and rehabilitation in patients with COPD
Session type: Thematic Poster Session
Number: 1811
Disease area: Airway diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Vonbank, G. Funk, R. Ziesche, V. Petkov, L. Stiebellehner, P. Schenk, P. Haber (Vienna, Austria). Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease. Eur Respir J 2002; 20: Suppl. 38, 1811

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006

The assessment of exercise capacity in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005

Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005

Stroke volume augmentation during exercise in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010

Determinants of exercise capacity in chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Exploring respiratory function
Year: 2020




Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010

Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Cardiac response to exercise in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009


Systemic inflammation and increased arterial stiffness in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003; 21: 58-67
Year: 2003



The impact of anemia of chronic disease on exercise capacity among patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Clinical physiology for clinical problems
Year: 2011

Outpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008


Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002

Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Renal function reserve in patients with mild and moderate chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 56s
Year: 2005

Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010